Niagen Bioscience, Inc.

NasdaqCM:NAGE Stock Report

Market Cap: US$603.9m

Niagen Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:NAGE Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Mar 25BuyUS$2,146Carlos LopezIndividual273US$7.86
22 Nov 24BuyUS$21,397Ozan PamirIndividual2,907.2US$7.36

Insider Trading Volume

Insider Buying: NAGE insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NAGE?
Owner TypeNumber of SharesOwnership Percentage
State or Government26,3680.0338%
Public Companies3,816,7944.9%
Institutions23,018,09529.5%
Individual Insiders23,234,48029.8%
General Public27,821,71035.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 59.04% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.8%
Hoi Shuen Chau
19,294,356US$149.5m0%no data
4.9%
Nestlé S.A.
3,816,794US$29.6m0%no data
4.64%
BlackRock, Inc.
3,611,585US$28.0m6.37%no data
4.35%
The Vanguard Group, Inc.
3,389,547US$26.3m-1.19%no data
3.32%
Tieton Capital Management, LLC
2,588,614US$20.1m-12.4%8.35%
2.98%
Frank Jaksch
2,319,231US$18.0m0.56%no data
2.03%
Robert Fried
1,580,061US$12.2m0%no data
1.66%
ICONIQ Capital, LLC
1,296,354US$10.0m0%0.18%
1.48%
Geode Capital Management, LLC
1,154,778US$8.9m0.45%no data
1.3%
D. E. Shaw & Co., L.P.
1,011,290US$7.8m1,790%0.01%
1.17%
State Street Global Advisors, Inc.
914,975US$7.1m48.1%no data
0.91%
Renaissance Technologies LLC
712,788US$5.5m68%0.01%
0.85%
Arrowstreet Capital, Limited Partnership
662,956US$5.1m288%no data
0.65%
Connor, Clark & Lunn Investment Management Ltd.
506,186US$3.9m189%0.02%
0.55%
Northern Trust Global Investments
429,873US$3.3m13.8%no data
0.45%
Qube Research & Technologies Ltd
346,918US$2.7m0%no data
0.42%
GAMCO Investors, Inc.
331,000US$2.6m-3.54%0.01%
0.42%
Columbia Management Investment Advisers, LLC
329,988US$2.6m213%no data
0.41%
JPMorgan Chase & Co, Brokerage and Securities Investments
319,144US$2.5m2.73%no data
0.4%
Point72 Asset Management, L.P.
310,369US$2.4m0%0.01%
0.29%
Millennium Management LLC
226,089US$1.8m0%no data
0.28%
Los Angeles Capital Management LLC
218,528US$1.7m617%0.01%
0.28%
Tudor Investment Corporation
217,568US$1.7m0%0.02%
0.27%
State of Wisconsin Investment Board
210,700US$1.6m1,890%no data
0.26%
Acuitas Investments, LLC
202,065US$1.6m-21.7%0.77%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/24 22:03
End of Day Share Price 2025/03/24 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Niagen Bioscience, Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey Van SinderenB. Riley Securities, Inc.
Robert WassermanDawson James Securities
Jeffrey MarkFarmhouse Equity Research